On the role of menopause for sleep-endocrine alterations associated with major depression

Psychoneuroendocrinology. 2003 Apr;28(3):401-18. doi: 10.1016/s0306-4530(02)00031-8.

Abstract

Aging and menopause are associated with alterations of the sleep EEG, while age-related changes of the hypothalamo-pituitary-adrenal (HPA) axis remain controversial. Major depression is also associated with typical sleep-endocrine changes, including enhanced activity of the HPA axis, while an influence of age and gender on these alterations is less clear. To test the hypothesis that after menopause sleep-endocrine alterations associated with major depression are accentuated, we examined the sleep EEG and nocturnal hormone secretion (ACTH, cortisol, GH, estradiol, LH, FSH, and leptin) in 16 drug-free female patients, mostly with the first episode of a major depressive disorder (seven pre- and nine postmenopausal subjects) and 19 female controls (10 subjects in the early follicular phase and nine postmenopausal subjects). Nocturnal cortisol secretion was increased in postmenopausal patients with depression, while a decrease was noted in postmenopausal controls. Sleep alterations typically associated with depression, namely a reduction in sleep continuity and slow wave sleep (SWS) and an increase in REM density, were prominent in post- but not in premenopausal patients. An inverse correlation was noted between the decline in SWS and sleep continuity and FSH secretion in patients with depression, suggesting a role of menopause for these sleep-endocrine alterations typically associated with major depression. In contrast, in premenopausal patients we noted primarily a shift in SWS and delta-EEG activity from the first to the second non-REM period, which was not related to age or hormone secretion. Though the relatively small number of subjects per group precludes a definitive conclusion, our data open up the possibility that the sleep-endocrine changes typically associated with major depression are most prominent in postmenopausal patients. Whether the predominant alteration of the distribution of SWS and delta EEG activity in younger patients with a first episode of major depression has a predictive value for the future course of the disease remains to be investigated.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Aged
  • Depressive Disorder, Major / complications
  • Depressive Disorder, Major / physiopathology*
  • Electroencephalography
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Human Growth Hormone / blood
  • Humans
  • Hydrocortisone / blood*
  • Leptin / blood
  • Luteinizing Hormone / blood
  • Matched-Pair Analysis
  • Menopause / physiology*
  • Menopause / psychology
  • Middle Aged
  • Pituitary Hormones, Anterior / blood*
  • Polysomnography
  • Sleep Wake Disorders / complications
  • Sleep Wake Disorders / physiopathology*
  • Sleep, REM / physiology
  • Statistics as Topic

Substances

  • Leptin
  • Pituitary Hormones, Anterior
  • Human Growth Hormone
  • Estradiol
  • Adrenocorticotropic Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Hydrocortisone